Dr. Salehi-Had is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7812 Edinger Ave
Suite 202
Huntington Beach, CA 92647Phone+1 714-901-2006Fax+1 714-901-2004- Is this information wrong?
Summary
- Dr. Hani Salehi-Had is an ophthalmologist in Huntington Beach, CA and is affiliated with multiple hospitals in the area, including Hoag Memorial Hospital Presbyterian, MemorialCare, Orange Coast Memorial Medical Center, MemorialCare, Long Beach Memorial Medical Center, Los Alamitos Medical Center, and Torrance Memorial Medical Center. He received his medical degree from University of California Davis School of Medicine and has been in practice 12 years. He specializes in retinal disease and is experienced in diabetic retinopathy, retinal detachment, optical coherence tomography, ocular trauma, and macular degeneration.
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Surgical Retina and Vitreous, 2009 - 2011
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2006 - 2009
- St Mary's Hospital and Medical CenterInternship, Internal Medicine, 2005 - 2006
- University of California, Davis, School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2009 - 2024
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
- Efficacy and Safety of RTH258 Versus Aflibercept - Study 1 Start of enrollment: 2014 Dec 08
- Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration Start of enrollment: 2015 Jun 25
Publications & Presentations
PubMed
- 1 citationsIntravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.David M Brown, David S Boyer, Diana V Do, Charles C Wykoff, Taiji Sakamoto, Peter Win, Sunir Joshi, Hani Salehi-Had, András Seres, Alyson J Berliner, Sergio Leal, Robe...> ;Lancet. 2024 Mar 23
- Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.Humayun, M., Clegg, D., Dayan, M., Kashani, A., Rahhal, F., Avery, R., Salehi-Had, H., Chen, S., Chan, C., Palejwala, N., Ingram, A., Mitra, D., Pennington, B., Hinman...> ;Ophthalmology. 2023 Dec 30
- 10 citationsFour-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.Raj K Maturi, Adam R Glassman, Kristin Josic, Carl W Baker, Adam T Gerstenblith, Lee M Jampol, Annal Meleth, Daniel F Martin, Michele Melia, Omar S Punjabi, Soraya Rof...> ;JAMA. 2023 Feb 7
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Long Beach Medical CenterLong Beach, California
- Los Alamitos Medical CenterLos Alamitos, California
- Torrance Memorial Medical CenterTorrance, California
External Links
- Retina Associates of Southern California https://retinasocal.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: